Finch Therapeutics Group Inc (FNCH)
12.12
+0.17
(+1.45%)
USD |
OTCM |
Nov 05, 14:06
Finch Therapeutics Group Total Assets (Quarterly): 45.58M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 45.58M |
| March 31, 2024 | 50.09M |
| December 31, 2023 | 55.37M |
| September 30, 2023 | 59.49M |
| June 30, 2023 | 66.86M |
| March 31, 2023 | 79.04M |
| December 31, 2022 | 162.94M |
| September 30, 2022 | 187.97M |
| Date | Value |
|---|---|
| June 30, 2022 | 228.30M |
| March 31, 2022 | 204.63M |
| December 31, 2021 | 225.37M |
| September 30, 2021 | 232.98M |
| June 30, 2021 | 250.33M |
| March 31, 2021 | 265.95M |
| December 31, 2020 | 165.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.58M
Minimum
Jun 2024
265.95M
Maximum
Mar 2021
152.02M
Average
165.34M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.36M |
| Shareholders Equity (Quarterly) | 14.22M |